Pharmacokinetics, Safety, and Tolerability of SYN-020

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

May 18, 2021

Study Completion Date

September 30, 2021

Conditions

Enteritis Caused by Radiation (Disorder)

Interventions

DRUG

SYN-020 delayed release capsule

SYN-020, is an opaque, white, size 3 HPMC capsule for oral administration containing enteric-coated, delayed-release pellets.

Trial Locations (1)

Spaulding Clinical Research LLC, West Bend

All Listed Sponsors

collaborator

Spaulding Clinical Research LLC

OTHER

lead

Theriva Biologics, Inc.

INDUSTRY

NCT04815993 - Pharmacokinetics, Safety, and Tolerability of SYN-020 | Biotech Hunter | Biotech Hunter